Webinar live date: Monday 15 June 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Learn how LC–MS/MS targeted quantification approaches can provide the highest possible sensitivity and selectivity for host cell proteins for biotherapeutic production.
Webinar live date: Tuesday 26 May 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. As COVID-19 is shutting down countries, particularly locking down travel, we discuss the impact on blood sample collection and how a patient-centric sampling approach could help mitigate these challenges and how the approach could be part of our new normal.
Webinar live date: Tuesday 9 June 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Development and optimization of a fit-for-purpose, fully qualified biotherapeutic PK assay on a microfluidic, automated immunoassay platform enhances workflow efficiency and minimizes human error.
Webinar date: Thursday 28 May 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. With the ongoing COVID-19 pandemic extensively impacting clinical trials irrespective of indication, learn how bioequivalence studies (BCS) can be a suitable stop-gap measure in the interim.
Thursday 7th May 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. We discuss the translation of a diagnostic virus neutralization method to a quantitative relative potency for an anti-viral antibody, using the example of an anti-influenza antibody.
Wednesday 13 May 2020 15:00 [BST] 11:00 [EDT] 08:00 [PDT]. Join Frontage Laboratories, Inc. (MA, USA) for the presentation of ‘Biomarker bioanalysis support to drug development and personalized medicine’.
To celebrate International Women’s Day 2020, Bioanalysis Zone brought together a panel of experts to discuss issues surrounding gender parity in bioanalysis. This round-up summarizes our key take home messages from the expert panel.
View now on demand. With ChipCytometry by Canopy Biosciences (MO, USA), you can phenotype each cell in your tissue sample individually, retaining morphology and spatial information.
Available on demand. Live date. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion focusing on new technologies. The panelists discuss how the bioanalytical field could learn from other industries and why we should be introducing new technologies.
At the virtual ASMS 2020 Reboot conference, Bruker (MA, USA) announced the first commercially available matrix-assisted laser desorption ionization-2 (MALDI-2) source, along with the innovations in Bruker’s proteomics platforms.
Scientists from the University of Birmingham (UK) are in the process of developing a new blood test that could facilitate earlier and more accurate prostate cancer detection.
Thermo Fisher Scientific (MA, USA) has expanded its Orbitrap platform with the release of new software functionalities and two new generation high-resolution mass spectrometers, which are being showcased at ASMS 2020 Reboot.
New study published in Current Research in Biotechnology reports the development of a model for computational prediction of glycosylation of recombinant proteins, which would be of a very high value in the development of future biopharmaceuticals.
In this interview we caught up with Jian Guo (University of British Columbia, Vancouver, Canada) to discuss his research inspirations, current research focus and what he hopes attendees will gain from his presentation at ASMS 2020 Reboot.